Table 5.
Convergent validity estimates for the MEX benefits and barriers subscales and existing scales
| Scale | N | M (SD) | Benefits r | Barriers r | Fisher’s Z |
|---|---|---|---|---|---|
| Sample 1 | |||||
| MEX-Benefits | 492 | 46.8 (6.96) | – | – | – |
| MEX-Barriers | 492 | 35.8 (11.7) | 0.1*✝ | – | – |
| DASS-Depression | 466 | 16.9 (12.6) | 0.03 | 0.725*** | 12.314*** |
| DASS-Anxiety | 457 | 17.3 (13.7) | 0.111* | 0.703*** | 10.51*** |
| DASS-Stress | 462 | 16.9 (11.6) | 0.093* | 0.707*** | 10.881*** |
| SWLS | 482 | 22.8 (7.26) | 0.271*** | 0.092* | 2.719** |
| MET·mins/week | 344 | 2972 (2102) | 0.276*** | 0.164** | 1.407 |
| SPAF | 480 | 13.2 (3.42) | 0.377*** | 0.097* | 4.363*** |
| SDE | 492 | 4.15 (0.782) | 0.149** | −0.337*** | 7.462*** |
| IM | 492 | 4.21 (0.822) | −0.018 | −0.254*** | 3.582*** |
| Sample 2/3 | |||||
| MEX-Benefits | 605 | 45.8 (7.58) | – | – | – |
| MEX-Barriers | 605 | 35.6 (8.83) | −0.454*** | – | – |
| MASQ-AA | 605 | 28.1 (10.1) | −0.033 | 0.306*** | 5.003*** |
| MASQ-AD | 605 | 97.5 (12.0) | −0.195*** | 0.466*** | 10.086*** |
| MASQ-GDD | 605 | 30.1 (11.1) | −0.174*** | 0.464*** | 9.721*** |
| MASQ-GDA | 605 | 23.2 (7.56) | −0.107** | 0.394*** | 7.527*** |
| MASQ-GDM | 605 | 38.9 (11.9) | −0.154*** | 0.459*** | 9.337*** |
| SPAF | 605 | 10.9 (3.18) | 0.437*** | −0.606*** | 16.823*** |
| LTSES | 605 | 0.815 (0.99) | 0.335*** | −0.451*** | 11.998*** |
Correlations significant at p < .001 are emphasized in bold
DASS Depression Anxiety Stress Scale, SWLS Satisfaction with Life Scale, MET Metabolic Equivalents of Physical Activity (minutes per week), SPAF Subjective Physical Activity and Fitness, LTSES Leisure-Time Sport and Exercise Score, SDE Self-Deceptive Enhancement, IM Impression Management, MASQ Mood, Anxiety, and Stress Questionnaire, AA Anxious Arousal, AD Anhedonic Depression, GDD General Distress: Depression, GDA General Distress: Anxiety, GDM = General Distress: Mixed
*p < .05, **p < .005, ***p < .001
✝Non-parametric relationship